Advertisement

Topics

Companies Related to "A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors" [Most Relevant Company Matches] RSS

13:06 EDT 20th August 2018 | BioPortfolio

Here are the most relevant search results for "A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors" found in our extensive corporate database of over 50,000 company records.

Showing "Dose Finding Study Medication 00337210 That Will Possibly" Companies 1–25 of 1,100+

Relevant

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...


Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

Pharmeasy

Pharmeasy is Australia’s trusted provider of home and workplace delivered prescription medication and pharmacy items, providing personal assistance, savings and convenience to people with ongoing pharmacy requirements.As our name implies, Pharmeasy makes pharmacy easy! We take the worry out of finding your prescriptions, going to the pharmacy to get your medication(s) dispensed and even remember...


TOPICA Pharmaceuticals, Inc.

TOPICA Pharmaceuticals, Inc. is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, or fungal infections of the nail. The company is focused on conducting the Phase 2b/3 SOLUTION Study, a robust dose finding and proof of efficacy trial with luliconazole in onychomycosis with...

MediSafe Inc. and AppScript

MediSafe™ is a leading mobile medication management platform that reminds patients to take their medications via smartphones and tablets, serving to improve medication adherence rates and curb the growing annual health care costs globally. The personalized application – already downloaded by more than 1.4 million users worldwide – alerts fam...

Institute for Safe Medication Practices

The Institute for Safe Medication Practices (ISMP), based in suburban Philadelphia, is the nation’s only 501c (3) nonprofit organization devoted entirely to medication error prevention and safe medication use. ISMP represents over 30 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. The organization is...

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...

CleverCap

CleverCap® is a medication adherence platform designed for clinical trial professionals in order to manage adherence and the data associated with participant compliance, trial reporting and analysis. The CleverCap device-enabled medication adherence solution helps patients take the right dose, at the right time, combined with alerts, tracking, third-par...

Pharmacy Advantage

Pharmacy Advantage is a Michigan-based organization that provides compassionate care as well as comprehensive Medication Therapy Management Programs to patients with acute and chronic conditions. Incorporated specialty services: free prescription delivery, benefits investigation, financial assistance programs and disease specific clinical counsel...

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

CompuMed Incorporated

CompuMed Medication Management System automatically dispenses the proper medication at the right time. All other medicine is locked in a tamperproof medication cassette. At preset times medication is automatically dispensed into an easily accessed drawer. When medicine is dispensed, an audio alarm sounds and instructions appear on a screen (i.e. "Take with food"). Optional reminders include a flas...

CareKinesis, Inc.

CareKinesis is a technology-enabled national medication risk mitigation pharmacy with advanced web-based medication decision support and adherence software, focused on organizations that service individuals with complex medication needs. For more information, visit www.carekinesis.com.

Finding Pharma

Based in Scottsdale, Arizona, Finding Pharma is a placement agency that connects the top five percent of candidates with the top five percent of employers in the pharmaceutical industry. Finding Pharma works with select companies to identify uniquely qualified candidates for exclusive positions. To learn more about the company’s services for candidates and ...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

MediSafe Project

MediSafe Project is the first cloud-synced mobile app helping families prevent emergencies caused by over- or under-dosing medications. In addition to reminding users when it’s time to take their medication, MediSafe Project sends alerts to selected family members, friends and caretakers when a loved one misses a dose. Aggregated patient behavior data...

MEPS Real-Time Inc.

Founded in 2006 and headquartered in Carlsbad, Calif., MEPS Real-Time, Inc. (mepsrealtime.com) is a leading provider of Radio Frequency Identification (RFID) solutions for pharmacy automation and inventory management. Its suite of Intelliguard® RFID Management Systems offer unprecedented real-time visibility of high-value, critical-dose pharmaceutical i...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

Broncho-Dose

Broncho-Dose Pharmacy provides home-delivered nebulizer medications. Our team of pharmacy specialists provides an outstanding level of customer service to respiratory patients nationwide.

CanTrustRx Inc.

CanTrustRx was created to provide an alternate source for prescription medications to help our neighbours around the world cope with their soaring medication costs. We can offer you savings of up to 70 % on brand-name and generic drugs through our licensed Canadian pharmacy. With over 30 years of experience in helping people achieve better heath, our dedicated and caring staff are ready to help yo...

Ameritox

The single-group, multi-dose study examined the ability of the Rx Guardian(SM) algorithm to differentiate among low, medium and high daily doses of OxyContin®. Oxycodone levels were detected in the urine of 36 healthy volunteers using a liquid chromatography-mass spectrometry (LC-MS-MS) assay. Participants were randomized to receive 80mg, 160mg or 240mg of daily OxyContin® to steady state cond...

Apothetrac

Apothetrac is dedicated to providing quality software to the hospital pharmacy market. We specialize in applying handheld bar code technology to the medication delivery process within the hospital. We offer the fastest, most cost effective way to locate misplaced medication deliveries.Our multidisciplinary development team consists of pharmacists and nurses working in hospitals. Our staff has over...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Bespak Europe

Bespak, founded more than 40 years ago, has established a reputation as a leading supplier of drug delivery technologies and services to the pharmaceutical and biotechnology industries.The company’s comprehensive capabilities have enabled it to develop proprietary drug delivery devices and technologies, many protected by worldwide patents. These include pressurised metered dose inhalers and actu...

Advanced Vision Therapies, Inc

Advanced Vision Therapies, Inc. (AVT) is focused on the treatment of sight-threatening eye diseases, such as age-related macular degeneration and finding a cure that works. The market, which is of a multi-billion dollar magnitude, and represents significant unmet medical needs, has been underserved by large pharma. Recent clinical trial data suggest that these diseases will be treatable, but with ...


More From BioPortfolio on "A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks